COMPUGEN LTD
COMPUGEN LTD (CGEN): 5 pipeline candidates · 2 upcoming catalysts · ~13 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
12.8 months
0% dilution
Lead: Phase 1/Phase 2
5 candidates
2 upcoming, next in ~286d
0 buys · 10 sells (180d)
A transparent, data-derived signal for COMPUGEN LTDacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$188.2M
Cash
$90.6M
Quarterly Burn
$32.2M
Runway
12.8 mo
Revenue
$72.8M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| cohort expansion | Phase 1 |
| com503 | Phase 1 |
| com701 | Phase 1/Phase 2 |
| dose escalation | Phase 1 |
| zimberelimab | Phase 1 |
Upcoming Catalysts (2)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
75
Total value held
$28.5M
| Holder | Shares | Value |
|---|---|---|
| silverarc capital management, llc | 3,315,845 | $7.1M |
| renaissance technologies llc | 1,632,988 | $3.5M |
| morgan stanley | 1,053,229 | $2.2M |
| ark investment management llc | 1,049,873 | $2.2M |
| nomura asset management international inc. | 1,020,000 | $2.2M |
| northern trust corp | 650,868 | $1.4M |
| two sigma investments, lp | 521,587 | $1.1M |
| state street corp | 415,366 | $885K |
| ubs group ag | 306,708 | $653K |
| wells fargo & company/mn | 3,100 | $646K |
Showing top 10 of 75 institutional holders of COMPUGEN LTD. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in COMPUGEN LTD's pipeline?
COMPUGEN LTD (CGEN) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is COMPUGEN LTD's lead drug candidate?
COMPUGEN LTD's most advanced tracked candidate is cohort expansion (Phase 1) for Advanced Cancer.
What is COMPUGEN LTD's next catalyst?
COMPUGEN LTD's next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: com701" — expected March 31, 2027.
What is COMPUGEN LTD's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, COMPUGEN LTD has approximately 12.8 months of cash runway.
What is COMPUGEN LTD's market capitalization?
COMPUGEN LTD's market capitalization is approximately $188.2M.
Get the full picture on COMPUGEN LTD
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.